retatrutide clinical trials phase 2 Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Retatrutide Phase 2: Type 2
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6






/assets/images/provider/photos/2775905.jpeg)


















